Azza Ismail
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Azza Ismail has a total of 9 co-authors. Here are the top co-authors by number of shared publications:
- Richard K. Burt
Northwestern University (retired), Scripps hematology, La Jolla, USA
2 shared publications - Basil Sharrack
University of Sheffield Sheffield United Kingdom
1 shared publication - Hany Ezzat Obaya
Department of Cardio-vascular/Respiratory Disorder and Geriatrics, Faculty of Physical Therapy , Cairo University , Cairo , Egypt
1 shared publication Helen Jessop
1 shared publication- Joachim Burman
Department of Medical Sciences, Uppsala University, Uppsala, Sweden
1 shared publication - John A. Snowden
Department of Haematology, Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, UK
1 shared publication
Latest Publications
- Open Access
- 15 November 2023
- Published by National Medical Research Center For Rehabilitation And Balneology in Bulletin of Rehabilitation Medicine
- Vol. 22 (5)
Expiratory Muscle Training Versus Functional Electrical Stimulation on Pulmonary and Swallowing Functions in Acute Stroke Patients
INTRODUCTION. Post-stroke dysphagia is reported in 30–50 % of stroke population. It increases mortality rate and leads to serious complications such as expiratory muscle affection which is a major cause of defective swallowing and ineffective airway protection. Expiratory muscle strength training (EMST) and functional electrical stimulation (FES) are recommended techniques to improve expiratory muscles performance. AIM. To compare the effect of EMST to that of FES on pulmonary and swallowing functions in acute stroke patients. MATERIAL AND METHODS. Seventy-two patients with post-stroke dysphagia were divided into two groups. Both groups received traditional dysphagia treatment. In addition, the first group received EMST and the second received neck and abdominal FES. Pulmonary functions were measured before and after in form of forced vital capacity (FVC), forced expiratory volume in one second (FEV1), FEV1/FVC ratio and peak expiratory flow (PEF), and arterial blood gases (ABG) while the Gugging Swallowing Scale (GUSS) was used as an indicator of swallowing function results of both groups were compared after one month of treatment. RESULTS. The post-treatment GUSS, FVC, FEV1 and PEF of the EMST group showed more significant increase compared to the FES group (p 0.05) with no significant differences in FEV1/FVC (p 0.05). Regarding ABG, there was more significant decrease in PaCO2 and HCO3 of EMST group compared to FES group (p 0.01). CONCLUSION. EMST was more effective than FES when it comes to improving expiratory and swallowing functions in patients with post-stroke dysphagia.
- 15 November 2023
- Published by National Medical Research Center For Rehabilitation And Balneology in Bulletin of Rehabilitation Medicine
- Vol. 22 (5)
Open AccessExpiratory Muscle Training Versus Functional Electrical Stimulation on Pulmonary and Swallowing Functions in Acute Stroke Patients
INTRODUCTION. Post-stroke dysphagia is reported in 30–50 % of stroke population. It increases mortality rate and leads to serious complications such as expiratory muscle affection which is a major cause of defective swallowing and ineffective airway protection. Expiratory muscle strength training (EMST) and functional electrical stimulation (FES) are recommended techniques to improve expiratory muscles performance. AIM. To compare the effect of EMST to that of FES on pulmonary and swallowing functions in acute stroke patients. MATERIAL AND METHODS. Seventy-two patients with post-stroke dysphagia were divided into two groups. Both groups received traditional dysphagia treatment. In addition, the first group received EMST and the second received neck and abdominal FES. Pulmonary functions were measured before and after in form of forced vital capacity (FVC), forced expiratory volume in one second (FEV1), FEV1/FVC ratio and peak expiratory flow (PEF), and arterial blood gases (ABG) while the Gugging Swallowing Scale (GUSS) was used as an indicator of swallowing function results of both groups were compared after one month of treatment. RESULTS. The post-treatment GUSS, FVC, FEV1 and PEF of the EMST group showed more significant increase compared to the FES group (p 0.05) with no significant differences in FEV1/FVC (p 0.05). Regarding ABG, there was more significant decrease in PaCO2 and HCO3 of EMST group compared to FES group (p 0.01). CONCLUSION. EMST was more effective than FES when it comes to improving expiratory and swallowing functions in patients with post-stroke dysphagia.
- 27 September 2021
- Published by Taylor & Francis
- p. 241-251
Early Toxicity and Supportive Care of Hsct for Autoimmune Diseases
HSCT is an intensive cytotoxic treatment and significant transplant-related toxicities are inevitable. Careful pretransplant evaluation and supportive care are important during all phases of the procedure, which should be delivered in specialized and accredited centers. Multidisciplinary collaboration between the transplant team and relevant disease specialists is key to optimizing care and outcomes according to specific autoimmune diseases. This chapter summarizes the organizational aspects of the transplant program, infrastructure, personnel, pretransplant preparations, counselling and workup, early complications and their supportive care management, all of which are essential to delivering patients safely through the HSCT procedure, with special consideration of the unique aspects of the HSCT care pathway of patients with autoimmune diseases.
- 27 September 2021
- Published by Taylor & Francis
- p. 241-251
Early Toxicity and Supportive Care of Hsct for Autoimmune Diseases
HSCT is an intensive cytotoxic treatment and significant transplant-related toxicities are inevitable. Careful pretransplant evaluation and supportive care are important during all phases of the procedure, which should be delivered in specialized and accredited centers. Multidisciplinary collaboration between the transplant team and relevant disease specialists is key to optimizing care and outcomes according to specific autoimmune diseases. This chapter summarizes the organizational aspects of the transplant program, infrastructure, personnel, pretransplant preparations, counselling and workup, early complications and their supportive care management, all of which are essential to delivering patients safely through the HSCT procedure, with special consideration of the unique aspects of the HSCT care pathway of patients with autoimmune diseases.
- 27 September 2021
- Published by Taylor & Francis
- p. 344-354
Multiple Sclerosis
The pathogenesis of multiple sclerosis remains unclear although a complex interplay between genetic and environmental factors plays a significant role. MS commonly affects young people with a predominate female-to-male prevalence ratio (2.0–3.5:1) , and is considered the most common cause of disability in young adults. Changes in diagnostic criteria have allowed early diagnosis and early initiation of treatment. In the last 25 years, there has been a significant expansion in therapeutic options, including hematopoietic stem cell transplantation (HSCT), which has revolutionized the management of this condition and resulted in a significant positive impact on affected individuals. In this chapter, we discuss the epidemiology, risk factors, immunopathology, diagnosis, and management of MS.
- 27 September 2021
- Published by Taylor & Francis
- p. 344-354
Multiple Sclerosis
The pathogenesis of multiple sclerosis remains unclear although a complex interplay between genetic and environmental factors plays a significant role. MS commonly affects young people with a predominate female-to-male prevalence ratio (2.0–3.5:1) , and is considered the most common cause of disability in young adults. Changes in diagnostic criteria have allowed early diagnosis and early initiation of treatment. In the last 25 years, there has been a significant expansion in therapeutic options, including hematopoietic stem cell transplantation (HSCT), which has revolutionized the management of this condition and resulted in a significant positive impact on affected individuals. In this chapter, we discuss the epidemiology, risk factors, immunopathology, diagnosis, and management of MS.